对《首次巩固治疗后的可测量残留病预测接受全反式维甲酸和化疗的急性早幼粒细胞白血病患者的预后》一文的更正
Correction to: Measurable residual disease after the first consolidation predicts the outcomes of patients with acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy.
作者信息
Henzan Hideho, Takase Ken, Kamimura Tomohiko, Mori Yasuo, Yoshimoto Goichi, Iwasaki Hiromi, Nagafuji Koji, Ogawa Ryosuke, Eto Tetsuya, Uchida Naoyuki, Fujisaki Tomoaki, Kato Koji, Minami Mariko, Kikushige Yoshikane, Akashi Koichi, Miyamoto Toshihiro
机构信息
Department of Hematology, Hamanomachi Hospital, Fukuoka, Japan.
Department of Hematology, National Kyushu Medical Center, Fukuoka, Japan.
出版信息
Int J Hematol. 2020 Sep;112(3):431-432. doi: 10.1007/s12185-020-02932-8.
PMID:32643074
Abstract
In the original publication of the article, the "CNS involvement" in the last row under the column "Total N=50" has been published incorrectly. The correct Table 1 is given in this correction.
摘要
在该文章的原始发表中，“总计N = 50”列下最后一行的“中枢神经系统受累情况”发布有误。此勘误给出了正确的表1。
Zotero 插件